These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38840177)

  • 1. The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak.
    Azzam A; Khaled H; Salem H; Ahmed A; Heniedy AM; Hassan HS; Hassan A; El-Mahdy TS
    Virol J; 2024 Jun; 21(1):130. PubMed ID: 38840177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mpox severity and associated hospitalizations among people with HIV and related immunosuppression in Brazil.
    Silva MST; Coutinho C; Torres TS; Peixoto EM; Bastos MO; Mesquita MB; Tavares ICF; Andrade HB; Reges PPS; Martins PS; Echeverría-Guevara A; Moreira RI; Lessa FCS; Hoagland B; Nunes EP; Cardoso SW; Veloso VG; Grinsztejn B;
    AIDS; 2024 Jan; 38(1):105-113. PubMed ID: 37812389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low CD4 Count or Being Out of Care Increases the Risk for Mpox Hospitalization Among People With Human Immunodeficiency Virus and Mpox.
    Philpott DC; Bonacci RA; Weidle PJ; Curran KG; Brooks JT; Khalil G; Feldpausch A; Pavlick J; Wortley P; O'Shea JG
    Clin Infect Dis; 2024 Mar; 78(3):651-654. PubMed ID: 37590957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monkeypox (mpox) in immunosuppressed patients.
    Ahmed SK; Mohamed MG; Dabou EA; Abuijlan I; Chandran D; El-Shall NA; Chopra H; Dhama K
    F1000Res; 2023; 12():127. PubMed ID: 37089133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox.
    Garneau WM; Jones JL; Dashler GM; Mostafa HH; Judson SD; Kwon N; Hamill MM; Gilliams EA; Rudolph DS; Keruly JC; Fall A; Klein EY; Hansoti B; Gebo KA
    Open Forum Infect Dis; 2023 Dec; 10(12):ofad533. PubMed ID: 38058459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mpox in people living with HIV.
    Maan I; Kohli M; Gilson R
    Curr Opin Infect Dis; 2024 Feb; 37(1):1-7. PubMed ID: 38112084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between HIV and Severe Mpox in an Atlanta Cohort.
    Aldred B; Scott JY; Aldredge A; Gromer DJ; Anderson AM; Cartwright EJ; Colasanti JA; Hall B; Jacob JT; Kalapila A; Kandiah S; Kelley CF; Lyles RH; Marconi VC; Nguyen ML; Rebolledo PA; Sheth AN; Szabo B; Titanji BK; Wiley Z; Workowski K; Cantos VD
    J Infect Dis; 2024 Mar; 229(Supplement_2):S234-S242. PubMed ID: 38001044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review.
    Higgins E; Ranganath N; Mehkri O; Majeed A; Walker J; Spivack S; Bhaimia E; Benamu E; Hand J; Keswani S; Dunn D; Beam E; Razonable RR
    Am J Transplant; 2023 Dec; 23(12):1972-1979. PubMed ID: 37516243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and Monkeypox virus Localization in Tissues From Immunocompromised Patients With Severe or Fatal Mpox.
    Ritter JM; Martines RB; Bhatnagar J; Rao AK; Villalba JA; Silva-Flannery L; Lee E; Bullock HA; Hutson CL; Cederroth T; Harris CK; Hord K; Xu Y; Brown CA; Guccione JP; Miller M; Paddock CD; Reagan-Steiner S;
    J Infect Dis; 2024 Mar; 229(Supplement_2):S219-S228. PubMed ID: 38243606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long or complicated mpox in patients with uncontrolled HIV infection.
    Corma-Gómez A; Cabello A; Orviz E; Morante-Ruiz M; Ayerdi O; Al-Hayani A; Muñoz-Gómez A; Santos IL; Gómez-Ayerbe C; Rodrigo D; Riestra SR; Reus-Bañuls S; Silva-Klug A; Galindo MJ; Santos M; Serrano-Fuentes M; Faro-Míguez N; Pérez-Camacho I; Corona-Mata D; Morano L; López-Ruz MÁ; Montero M; Anaya-Baz B; Merino D; Castillo-Navarro A; Pineda JA; Macías J
    J Med Virol; 2024 Mar; 96(3):e29511. PubMed ID: 38469884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mpox and HIV: a Narrative Review.
    Saldana CS; Kelley CF; Aldred BM; Cantos VD
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of HIV and mpox co-infection on clinical outcomes: Systematic review and meta-analysis.
    Taha AM; Elrosasy A; Mahmoud AM; Saed SAA; Moawad WAE; Hamouda E; Nguyen D; Tran VP; Pham HT; Sah S; Barboza JJ; Sah R
    HIV Med; 2024 Mar; ():. PubMed ID: 38443319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV viral load monitoring during monkeypox virus infection among people with HIV.
    Raccagni AR; Mileto D; Galli L; Bruzzesi E; Canetti D; Rizzo A; Bertoni C; Clemente T; Alberton F; Castagna A; Nozza S
    AIDS; 2023 Apr; 37(5):779-783. PubMed ID: 36689645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine - California, May 2022-May 2023.
    Schildhauer S; Saadeh K; Vance J; Quint J; Salih T; Lo T; Keinde A; Chojolan E; Gotlieb E; Ramos M; Chapman E; Peters P; Watson J; Johnson KA; Tang EC; Jacobson K; Snyder RE
    MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(36):992-996. PubMed ID: 37676838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.
    Ogoina D; Dalhat MM; Denue BA; Okowa M; Chika-Igwenyi NM; Yusuff HA; Christian UC; Adekanmbi O; Ojimba AO; Aremu JT; Habila KL; Oiwoh SO; Tobin EA; Johnson SM; Olaitan A; Onyeaghala C; Gomerep SS; Alasia D; Onukak AE; Mmerem J; Unigwe U; Falodun O; Kwaghe V; Awang SK; Sunday M; Maduka CJ; Na'uzo AM; Owhin SO; Mohammed AA; Adeiza MA;
    Lancet Infect Dis; 2023 Dec; 23(12):1418-1428. PubMed ID: 37625431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.
    Essajee NM; Oddo-Moise H; Hagensee ME; Lillis RA; Maffei J; Butler I; Lovett A; Sokol T; Clement ME
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):587-592. PubMed ID: 37424520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Presentation of Mpox in People With and Without HIV in the United Kingdom During the 2022 Global Outbreak.
    Pilkington V; Quinn K; Campbell L; Payne L; Brady M; Post FA
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):581-586. PubMed ID: 37071153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management of severe mpox in patients with uncontrolled human immunodeficiency virus.
    Shishido AA; Street S
    J Med Virol; 2023 Dec; 95(12):e29277. PubMed ID: 38078663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, molecular, and histological characteristics of severely necrotic and fatal mpox in HIV-infected patients.
    Rajme-López S; Corral-Herrera EA; Tello-Mercado AC; Tepo-Ponce KM; Pérez-Meléndez RE; Rosales-Sotomayor Á; Figueroa-Ramos G; López-López K; Domínguez-Cherit JG; San-Martín-Morante O; Saeb-Lima M; Gamboa-Domínguez A; Ponce-de-León A; Crabtree-Ramírez B; Ramos-Cervantes P; Ruíz-Palacios GM
    AIDS Res Ther; 2023 Nov; 20(1):85. PubMed ID: 38012656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.